Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer.
Leann A LovejoyCraig D ShriverSvasti HaricharanRachel E EllsworthPublished in: International journal of environmental research and public health (2023)
Black women in the US have significantly higher breast cancer mortality than White women. Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women with hormone receptor positive and HER2 negative (HR+/HER2-) breast cancer, a subtype usually associated with favorable prognosis. In this review, we present data from an array of studies that demonstrate significantly higher mortality in Black compared to White women with HR+/HER2-breast cancer and contrast these data to studies from integrated healthcare systems that failed to find survival differences. Then, we describe factors, both biological and non-biological, that may contribute to disparate survival in Black women.
Keyphrases
- breast cancer risk
- polycystic ovary syndrome
- healthcare
- pregnancy outcomes
- cardiovascular events
- electronic health record
- free survival
- big data
- magnetic resonance imaging
- risk factors
- case control
- cervical cancer screening
- adipose tissue
- skeletal muscle
- computed tomography
- mass spectrometry
- young adults
- data analysis
- single cell
- contrast enhanced